Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
HAEMOPHILUS TYPE B CONJUGATE VACCINE bulk supplier for pharma manufacturers

Haemophilus Type B Conjugate Vaccine Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10 mcg+ 25mcg, 7.5 mcg + 125 mcg

Reference Brands: ActHIB (USA), Hiberix (USA), EasyFive-TT (India)

Category: Vaccines

It is indicated to prevent disease caused by Haemophilus influenzae type B for infants and children from 6 weeks to 5 years of age. The dosing and booster doses depend on your child’s age.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Haemophilus influenzae is a major cause of life-threatening childhood disease that causes pneumonia (lung infection) and meningitis (brain infection). A huge part of the population is at a high risk of contracting Haemophilus influenzae type b (Hib) infection during early life. Hence, it is essential to include this vaccine in all routine infant immunization programs to prevent this infection at a vulnerable age and through herd immunity.

Haemophilus Type B Conjugate Vaccine — third party manufacturing & bulk supply

Haemophilus Type B Conjugate Vaccine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Haemophilus Type B Conjugate Vaccine is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Haemophilus Type B Conjugate Vaccine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Haemophilus Type B Conjugate Vaccine →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Haemophilus Type B Conjugate Vaccine is used to prevent infections caused by Haemophilus influenzae type b (Hib). These infections can lead to serious diseases such as meningitis, pneumonia, epiglottitis, septicemia, and other invasive bacterial infections, especially in infants and young children.

Haemophilus Type B Conjugate Vaccine is made from purified capsular polysaccharide of Haemophilus influenzae type b that is chemically linked to a carrier protein. This conjugation improves the immune response, particularly in infants and young children.

Common trade names include ActHIB, Hiberix, PedvaxHIB, and HibTITER.

This vaccine is manufactured by several pharmaceutical companies including Sanofi Pasteur, GlaxoSmithKline (GSK), Merck, and Serum Institute of India.

The generic name is Haemophilus influenzae type b conjugate vaccine.

Brand names include ActHIB, Hiberix, PedvaxHIB, and HibTITER.

Haemophilus Type B Conjugate Vaccine is manufactured in multiple countries including the United States, France, Belgium, and India depending on the manufacturer.

Related Products

Respiratory Syncytial Virus Mrna Vaccine

Strength:
0.5 mL

Form: injection (prefilled syringe)

Reference Brands: mRESVIA (USA/EU)

View Details
Inactivated Vaccines

Strength:
Dose and concentration depend on formulations

Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution

Reference Brands: Sinovac Coronavac. Covaxin(EU)

View Details
Viral Vector Vaccines

Strength:
0.5 mL

Form: Intramuscular injectable suspension (IM)

Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)

View Details
Mrna-Based Vaccines

Strength:
30 µg and 100 µg

Form: Injectable suspension

Reference Brands: Comirnaty, Spikevax(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.